bpostgroup withdraws full-year 2023 financial guidance further to preliminary results of compliance review of services with the Belgian State Read more about bpostgroup withdraws full-year 2023 financial guidance further to preliminary results of compliance review of services with the Belgian State
Cellectis Implements CLLS52 for the First Time in the Clinic with Sanofi’s Alemtuzumab Read more about Cellectis Implements CLLS52 for the First Time in the Clinic with Sanofi’s Alemtuzumab
Schibsted ASA (SCHA/SCHB) - Repurchase of own shares Read more about Schibsted ASA (SCHA/SCHB) - Repurchase of own shares
Celyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid Price Read more about Celyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid Price
Lumi Gruppen AS: Minutes from annual general meeting Read more about Lumi Gruppen AS: Minutes from annual general meeting
UPDATE ON RECENT BUSINESS ACTIVITIES AND SOLIS BOND POSITION Read more about UPDATE ON RECENT BUSINESS ACTIVITIES AND SOLIS BOND POSITION
UPDATE ON RECENT BUSINESS ACTIVITIES AND SOLIS BOND POSITION Read more about UPDATE ON RECENT BUSINESS ACTIVITIES AND SOLIS BOND POSITION
Onxeo Reports Full Year 2022 Financial Results and Provides Clinical Development Updates Read more about Onxeo Reports Full Year 2022 Financial Results and Provides Clinical Development Updates